ArticleJournal for immunotherapy of cancer2025
Targeting the NLRP3 inflammasome abrogates cardiotoxicity of immune checkpoint blockers.
Yang Lu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
14 papers cite it
this papercites it